This inventor holds 6 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Mati Therapeutics Inc., Novelion Therapeutics Inc., Qlt Inc.. Active years: 2015-2020.
Company Filing History:
3 out of 37 
1 out of 2 
1 out of 35 
Years Active: 2015-2020
Title: Suzanne Cadden: A Pioneer in Visionary Innovations
Introduction
Suzanne Cadden, an accomplished inventor based in North Vancouver, Canada, has made significant contributions to the field of ocular health through her innovative patents. With a remarkable track record of six patents, her work continues to push the boundaries of therapeutic interventions for visual disorders.
Latest Patents
Cadden's latest inventions include groundbreaking therapeutic regimens designed to improve visual function in patients suffering from Retinitis Pigmentosa and related visual disorders that stem from an endogenous retinoid deficiency. One of her patents details the administration of a synthetic retinal derivative, such as a 9- or 11-cis retinyl ester, which aims to restore crucial visual functions, including visual acuity, visual fields, and retinal sensitivity.
In addition to this, she has developed a novel method for treating glaucoma and ocular hypertension. This innovative approach involves the sustained release of therapeutic agents through implanted lacrimal devices, effectively decreasing intraocular pressure in patients. This dual implantation technique exemplifies her commitment to improving patient outcomes in ocular care.
Career Highlights
Throughout her career, Suzanne Cadden has made notable contributions while working with leading companies in the biotechnology sector, including Mati Therapeutics Inc. and QLT Inc. Her innovative spirit and dedication to enhancing ocular health have positioned her as a leading figure in her field.
Collaborations
Cadden’s success is also attributed to her collaborative efforts with esteemed colleagues, such as Yong Hao and Deepank Utkhede. These partnerships have fostered a dynamic environment for innovative thinking and have played a key role in the development of her patented technologies.
Conclusion
Suzanne Cadden's work represents a significant advancement in the treatment of visual disorders, offering hope to many patients. As an inventor dedicated to improving ocular health, her contributions through her patents exemplify the power of innovation in medicine and the potential to enhance quality of life for individuals suffering from visual impairments.